<p>The PDAC tumor tissues (PDAC) were negative for cyclin D2 (A) and strongly positive for cyclin E2 (B), with a high PCNA proliferative index (C). The adjacent benign pancreatic tissues (ABPT) were negative for cyclin D2 was (D), and positive for cyclin E2, as observed in the ductal epithelial cells of ABPT (E). PCNA was very low in normal pancreatic tissues (F). The insets of A, B, and C show the negative controls. The inset in D indicates that cyclin D2 is a positive control of lung adenocarcinoma. Original magnification, 200×. Overall survival after resection of pancreatic cancer with the cyclinE2-positive versus cyclinE2-negative groups was not significant (<i>P</i> = 0.676) (G), whereas overall survival after resection of pancreatic c...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a low survival rate. This is no...
Aims:: Pancreatic cancer is an aggressive tumour following a multistep progression model through pre...
Pancreatic Ductal Adenocarcinoma (PDAC) is a malignant neoplasm and is the fourth leading cause of c...
[[abstract]]Background: Periampullary cancers, the incidence of which increases gradually with indus...
[[abstract]]Background: Periampullary cancers, the incidence of which increases gradually with indus...
Thirty-five endocrine tumors of the pancreas, 17 functioning and 18 nonfunctioning, were immunohisto...
Objective Pancreatic adenocarcinoma (PAAD) is one of the most lethal malignant tumors worldwide. Var...
<p>Serial sections of normal and diseased pancreatic tissue were stained for CXCL12, CXCR4, CXCR7, a...
Background: Pancreatic ductal carcinoma (PDAC) is one of the most aggressive cancers. Mutations or e...
Pancreatic differentiation 2 (PD2), an important subunit of the human PAF complex, was identified af...
<p>A. Strong and negative expression of HMGA2. B. Strong and negative expression of PSCA.</p
<p>Stromal cells in CP were negative for anti-proCOL11A1 mAb (A) and desmin (B) whereas a substantia...
<p>(A) Merged immunofluorescence image of Gr. IV PDAC tumor tissue showing DEspR+ expression (red) i...
Adenocarcinoma of the pancreas is one of the top ten leading causes of cancer deaths. In the UK appr...
: Pancreatic ductal adenocarcinoma (PDAC) is currently the most deadly cancer. Although characterize...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a low survival rate. This is no...
Aims:: Pancreatic cancer is an aggressive tumour following a multistep progression model through pre...
Pancreatic Ductal Adenocarcinoma (PDAC) is a malignant neoplasm and is the fourth leading cause of c...
[[abstract]]Background: Periampullary cancers, the incidence of which increases gradually with indus...
[[abstract]]Background: Periampullary cancers, the incidence of which increases gradually with indus...
Thirty-five endocrine tumors of the pancreas, 17 functioning and 18 nonfunctioning, were immunohisto...
Objective Pancreatic adenocarcinoma (PAAD) is one of the most lethal malignant tumors worldwide. Var...
<p>Serial sections of normal and diseased pancreatic tissue were stained for CXCL12, CXCR4, CXCR7, a...
Background: Pancreatic ductal carcinoma (PDAC) is one of the most aggressive cancers. Mutations or e...
Pancreatic differentiation 2 (PD2), an important subunit of the human PAF complex, was identified af...
<p>A. Strong and negative expression of HMGA2. B. Strong and negative expression of PSCA.</p
<p>Stromal cells in CP were negative for anti-proCOL11A1 mAb (A) and desmin (B) whereas a substantia...
<p>(A) Merged immunofluorescence image of Gr. IV PDAC tumor tissue showing DEspR+ expression (red) i...
Adenocarcinoma of the pancreas is one of the top ten leading causes of cancer deaths. In the UK appr...
: Pancreatic ductal adenocarcinoma (PDAC) is currently the most deadly cancer. Although characterize...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a low survival rate. This is no...
Aims:: Pancreatic cancer is an aggressive tumour following a multistep progression model through pre...
Pancreatic Ductal Adenocarcinoma (PDAC) is a malignant neoplasm and is the fourth leading cause of c...